首頁 > 市場調查報告書 > 製藥

全球良性前列腺增生治療市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

市場調查報告書

商品編碼

1342840

全球良性前列腺增生治療市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global Benign Prostatic Hyperplasia Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年08月01日 | 出版商:

Value Market Research | 英文 144 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球良性前列腺增生治療市場需求預計將從 2022 年的 103.4 億美元達到 2030 年的近 219.8 億美元，2023-2030 年研究期間年複合成長率為 8.74%。

BPH 代表良性前列腺增生，是前列腺內的非癌細胞增殖。前列腺內部首先受到影響。由於前列腺肥大，尿道逐漸受到壓縮。 BPH 藥物、手術和微創手術是治療 BPH 的可行藥物。這些手術有助於減少異常的前列腺生長或放鬆膀胱平滑肌。

市場動態：

進步的主要驅動力是良性前列腺增生（BPH）的高發病率、對微創手術的日益偏好，以及用於開發創新療法的贈款、投資和資金的增加。此外，前列腺增生症的發病率很大程度上受到人口老齡化的影響，尤其是老年男性群體，這推動了全球對藥品的需求。良性前列腺增生前列腺治療市場預計也將受益於肥胖、缺乏身體活動的增加以及人們對治療良性前列腺增生藥物的認知的提高。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球良性前列腺增生治療市場的各個細分市場進行了包容性評估。良性前列腺增生治療行業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲良性前列腺增生治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。良性前列腺增生治療市場的主要參與者包括波士頓科學公司、泰利福公司、Endo International Plc、Urologix LLC、LISA Laser、奧林巴斯公司。本節包含競爭格局的整體視圖，包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

按治療概述
歷史和預測數據
按治療分析
藥物類別（α-阻滯劑、5-α-還原酶抑製劑 (5-ARIs)、磷酸二酯酶 5 酶抑製劑、其他）
微創手術（經尿道前列腺切除術（TURP）、經尿道前列腺切開術（TUIP）、機器人手術、經尿道微波熱療（TUMT）、前列腺尿道提升術等）
雷射治療
其他

第 7 章：全球良性前列腺增生治療市場分析：按最終用戶分類

最終用戶概述
歷史和預測數據
最終用戶分析
醫院
門診手術中心
專科診所
其他

第 8 章：全球良性前列腺增生治療市場分析：按地理位置

區域展望
介紹
北美銷售分析
- 概述、歷史和預測銷售分析
- 北美按細分市場銷售分析
- 北美按國家/地區銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家/地區銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳大利亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家/地區銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：良性前列腺增生治療公司的競爭格局

良性前列腺增生治療市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市場佔有率分析
市場集中度
Boston Scientific Corporation

公司簡介
公司收入
產品
最近的發展

Teleflex Incorporated

公司簡介
公司收入
產品
最近的發展

Endo International Plc

公司簡介
公司收入
產品
最近的發展

Urologix LLC

公司簡介
公司收入
產品
最近的發展

LISA Laser

公司簡介
公司收入
產品
最近的發展

Olympus Corporation

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR11219538

The global demand for Benign Prostatic Hyperplasia Treatment Market is presumed to reach the market size of nearly USD 21.98 BN by 2030 from USD 10.34 BN in 2022 with a CAGR of 8.74% under the study period 2023 - 2030.

BPH stands for benign prostatic hyperplasia, which is a noncancerous cell proliferation inside the prostate gland. The inside of the prostate is first affected. The urethra then gradually becomes compressed as a result of prostatic enlargement. BPH medicines, surgery, and minimally invasive surgery are among viable medical treatments for BPH. These procedures aid in reducing the aberrant prostrate growth or relaxing the smooth bladder muscles.

MARKET DYNAMICS:

The main drivers of advancement are the high incidence of BPH, rising preference for minimally invasive procedures, and rising grants, investments, and funding for the development of innovative treatments. Furthermore, the incidence of BPH is greatly influenced by the ageing population, especially the senior male segment, which drives the demand for pharmaceuticals worldwide. The market for benign prostatic hyperplasia prostate treatment is also anticipated to benefit from the rise in obesity, physical inactivity, and increased awareness of the existence of drugs for treating benign prostatic hyperplasia.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of benign prostatic hyperplasia treatment. The growth and trends of benign prostatic hyperplasia treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the benign prostatic hyperplasia treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment

Drug Class (Alpha-Blockers, 5-Alpha-Reductase Inhibitor (5-ARIs), Phosphodiesterase-5 Enzyme Inhibitor, Others)
Minimally Invasive Surgeries (Transurethral Resection Of The Prostate (TURP), Transurethral Incision Of The Prostate (TUIP), Robotic Surgeries, Transurethral Microwave Thermotherapy (TUMT), Prostatic Urethral Lift, Others)
Laser Therapy
Others

By End-User

Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Benign Prostatic Hyperplasia Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the benign prostatic hyperplasia treatment market include Boston Scientific Corporation, Teleflex Incorporated, Endo International Plc, Urologix LLC, LISA Laser, Olympus Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . BENIGN PROSTATIC HYPERPLASIA TREATMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Treatment
- 3.7.2 Market Attractiveness Analysis By End-user
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET ANALYSIS BY TREATMENT

6.1 Overview by Treatment
6.2 Historical and Forecast Data
6.3 Analysis by Treatment
6.4 Drug Class (Alpha-blockers, 5-Alpha-reductase Inhibitor (5-ARIs), Phosphodiesterase-5 Enzyme Inhibitor, Others) Historic and Forecast Sales by Regions
6.5 Minimally Invasive Surgeries (Transurethral Resection of the Prostate (TURP), Transurethral Incision of the Prostate (TUIP), Robotic Surgeries, Transurethral Microwave Thermotherapy (TUMT), Prostatic Urethral Lift, Others) Historic and Forecast Sales by Regions
6.6 Laser Therapy Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Ambulatory Surgical Centers Historic and Forecast Sales by Regions
7.6 Specialty Clinics Historic and Forecast Sales by Regions
7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE BENIGN PROSTATIC HYPERPLASIA TREATMENT COMPANIES

9.1. Benign Prostatic Hyperplasia Treatment Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF BENIGN PROSTATIC HYPERPLASIA TREATMENT INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Boston Scientific Corporation
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Teleflex Incorporated
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Endo International Plc
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Urologix LLC
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. LISA Laser
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Olympus Corporation
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers : Impact Analysis
Restraints : Impact Analysis
List of Raw Material
List of Raw Material Manufactures
List of Potential Buyers
Analysis by Treatment (USD MN)
Drug Class (Alpha-blockers, 5-Alpha-reductase Inhibitor (5-ARIs), Phosphodiesterase-5 Enzyme Inhibitor, Others) Market Sales by Geography (USD MN)
Minimally Invasive Surgeries (Transurethral Resection of the Prostate (TURP), Transurethral Incision of the Prostate (TUIP), Robotic Surgeries, Transurethral Microwave Thermotherapy (TUMT), Prostatic Urethral Lift, Others) Market Sales by Geography (USD MN)
Laser Therapy Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Analysis Market by End-user (USD MN)
Hospitals Market Sales by Geography (USD MN)
Ambulatory Surgical Centers Market Sales by Geography (USD MN)
Specialty Clinics Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Benign Prostatic Hyperplasia Treatment Market Sales by Geography (USD MN)
North America Market Analysis (USD MN)
United State Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate by Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Benign Prostatic Hyperplasia Treatment Report
Market Research Process
Market Research Methodology
Global Benign Prostatic Hyperplasia Treatment Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Treatment
Market Attractiveness Analysis by End-user
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Treatment (USD MN)
Drug Class (Alpha-blockers, 5-Alpha-reductase Inhibitor (5-ARIs), Phosphodiesterase-5 Enzyme Inhibitor, Others) Market Sales by Geography (USD MN)
Minimally Invasive Surgeries (Transurethral Resection of the Prostate (TURP), Transurethral Incision of the Prostate (TUIP), Robotic Surgeries, Transurethral Microwave Thermotherapy (TUMT), Prostatic Urethral Lift, Others) Market Sales by Geography (USD MN)
Laser Therapy Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market Analysis by End-user (USD MN)
Hospitals Market Sales by Geography (USD MN)
Ambulatory Surgical Centers Market Sales by Geography (USD MN)
Specialty Clinics Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market by Revenue
North America Market by Revenue
Europe Market by Revenue
Asia Pacific Market by Revenue
Latin America Market by Revenue
Middle East & Africa Market by Revenue
Recent Development in Industry
Top Companies Market Share Analysis